NASDAQ:XLO

Xilio Therapeutics, Inc.

Stock

USD

Last Close

0.96

26/07 20:00

Market Cap

35.44M

Beta: -

Volume Today

88.76K

Avg: 29.09K

PE Ratio

−0.23

PFCF: −0.25

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-17.31M -	-55.22M 218.98%	-75.80M 37.27%	-88.22M 16.39%	-76.40M 13.40%
depreciation and amortization	240K -	1.06M 343.75%	1.50M 40.75%	1.85M 23.22%	1.90M 2.87%
deferred income tax	-1.74M -	126K 107.25%	222K 76.19%
stock based compensation	112K -	1.30M 1,057.14%	4.96M 282.56%	8.42M 69.91%	7.38M 12.37%
change in working capital	797K -	16.60M 1,983.06%	-11.80M 171.09%	2.00M 116.98%	-2.06M 202.94%
accounts receivables
inventory
accounts payables	970K -	2.93M 201.65%	-2.82M 196.31%	485K 117.21%	-2.06M 525.36%
other working capital	-173K -	13.68M 8,005.20%	-8.98M 165.70%	1.52M 116.91%	2.06M 35.81%
other non cash items	56K -	39K 30.36%	173K 343.59%	224K 29.48%	-1.50M 768.75%
net cash provided by operating activities	-17.84M -	-36.09M 102.27%	-80.75M 123.74%	-75.72M 6.23%	-68.62M 9.38%
investments in property plant and equipment	-715K -	-2.19M 206.01%	-1.10M 49.73%	-1.87M 69.73%	-486K 73.97%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites	-715K -	-2.19M 206.01%	-1.10M 49.73%	-1.87M 69.73%	-486K 73.97%
debt repayment	-190K -	-99K 47.89%	-1.08M 995.96%	-85K 92.17%	-6.75M 7,843.53%
common stock issued	60.02M -	10.13M 83.13%	116.36M 1,048.88%	16K 99.99%
common stock repurchased					194K -
dividends paid
other financing activites	190K -	10.03K 94.72%	145.39M 1,449,635.77%		8K -
net cash used provided by financing activities	60.02M -	10.03M 83.29%	260.67M 2,499.14%	-69K 100.03%	-6.55M 9,392.75%
effect of forex changes on cash
net change in cash	41.46M -	-28.25M 168.13%	178.82M 732.98%	-77.66M 143.43%	-75.66M 2.58%
cash at beginning of period	7.58M -	49.04M 547.21%	20.79M 57.61%	199.61M 860.15%	121.95M 38.91%
cash at end of period	49.04M -	20.79M 57.61%	199.61M 860.15%	121.95M 38.91%	46.29M 62.04%
operating cash flow	-17.84M -	-36.09M 102.27%	-80.75M 123.74%	-75.72M 6.23%	-68.62M 9.38%
capital expenditure	-715K -	-2.19M 206.01%	-1.10M 49.73%	-1.87M 69.73%	-486K 73.97%
free cash flow	-18.56M -	-38.28M 106.27%	-81.85M 113.83%	-77.59M 5.21%	-69.11M 10.93%

All numbers in USD (except ratios and percentages)